Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Top Performance

Predictions

sell
Emergent Biosolutions Inc.

Start price
Target price
Perf. (%)
€2.86
21.02.24
-
21.02.25
8.94%
02.03.24

Good culture
Probably not worthwhile Investment
No uniques
me8 
21.02.24 0%
sell
Energy Focus Inc.

Start price
Target price
Perf. (%)
€1.59
21.02.24
-
21.02.25
3.14%
02.03.24

Capable Management
No uniques
Probably not worthwhile Investment
Little innovation
me8 
21.02.24 0%
sell
Minerva Neurosciences Inc.

Start price
Target price
Perf. (%)
€7.79
19.02.24
€6.00
16.05.26
-69.17%
03.03.24

Could be very worthwhile Investment >20% year
BiotechBee 
19.02.24 60%
buy
Applied Therapeutics Inc

Start price
Target price
Perf. (%)
€5.80
19.02.24
-
19.02.25
10.34%
03.03.24

Could be worthwhile Investment >10% per year
thomasw 
19.02.24 50%
buy
Ardelyx Inc.

Start price
Target price
Perf. (%)
€8.30
19.02.24
-
19.02.25
2.41%
03.03.24

Could be worthwhile Investment >10% per year
thomasw 
19.02.24 50%
buy
Fibrogen Inc.

Start price
Target price
Perf. (%)
€2.14
19.02.24
-
19.02.25
-24.30%
03.03.24

Probably not worthwhile Investment
thomasw 
19.02.24 50%
sell
Sangamo Therapeutics Inc.

Start price
Target price
Perf. (%)
€1.40
19.02.24
-
19.02.25
-24.14%
04.03.24

Risky Investment
robertinio 
19.02.24 0%
sell
Applied Therapeutics Inc

Start price
Target price
Perf. (%)
€5.80
19.02.24
-
19.02.25
-14.83%
15.04.24

Risky Investment
robertinio 
19.02.24 0%
buy
Gritstone Oncology Inc

Start price
Target price
Perf. (%)
€2.01
18.02.24
-
18.02.25
-2.59%
03.03.24

Risky Investment
blaugold 
18.02.24 50%
buy
Factset Research Systems

Start price
Target price
Perf. (%)
€426.80
17.02.24
-
17.02.25
0.52%
02.03.24

Could be worthwhile Investment >10% per year
Leading role in innovation
Strong uniques
knallfrosch44665 
17.02.24 50%
buy
Intel Corp.

Start price
Target price
Perf. (%)
€40.75
17.02.24
€42.00
17.02.25
4.53%
04.03.24

Revenue growth >5% per year expected
Differentiated customer and product portfolio
Could be worthwhile Investment >10% per year
Good rating
Traumtanz 
17.02.24 50%
buy
Plug Power Inc.

Start price
Target price
Perf. (%)
€3.59
17.02.24
€4.00
17.02.25
3.06%
09.03.24

Good rating
Revenue growth > 30% per year expected
Higher EBIT margin than peer group
Fair valuation
Traumtanz 
17.02.24 50%
buy
Netflix Inc.

Start price
Target price
Perf. (%)
€548.20
16.02.24
€550.00
16.02.25
3.08%
05.03.24

Market Leader or Top 3
Well known brand
Very Future proof/growth oriented business model
Revenue growth > 30% per year expected
Traumtanz 
16.02.24 50%
buy
Salesforce.com

Start price
Target price
Perf. (%)
€270.20
16.02.24
€271.00
16.02.25
2.89%
27.02.24

Revenue growth > 30% per year expected
EBIT growth > 30% per year expected
Undervalued
Future proof or reliable business model
Traumtanz 
16.02.24 50%
sell
Fibrogen Inc.

Start price
Target price
Perf. (%)
€2.02
13.02.24
-
13.02.25
5.94%
17.02.24

Probably not worthwhile Investment
Vassago1 
13.02.24 50%
buy
Salesforce.com

Start price
Target price
Perf. (%)
€261.00
13.02.24
€270.00
13.02.25
3.52%
16.02.24

Revenue growth > 30% per year expected
EBIT growth > 30% per year expected
Undervalued
Future proof or reliable business model
Traumtanz 
13.02.24 50%
sell
Glatfelter Corp.

Start price
Target price
Perf. (%)
€2.24
07.02.24
€1.00
07.02.25
-10.69%
17.02.24

Good culture
No Innovation
Risky Investment
Below average Management
me8 
07.02.24 0%
buy
New York Community Bancorp

Start price
Target price
Perf. (%)
€3.75
06.02.24
-
06.02.25
22.30%
17.02.24

Could be worthwhile Investment >10% per year
Vassago1 
06.02.24 50%
buy
Uranium Energy Corp

Start price
Target price
Perf. (%)
€7.50
06.02.24
-
06.02.25
-5.31%
15.02.24

Dirk1 
06.02.24 50%
buy
Karyopharm Therapeutics Inc.

Start price
Target price
Perf. (%)
€1.35
05.02.24
-
05.02.25
29.34%
06.02.24

Could be worthwhile Investment >10% per year
Capable Management
Good culture
Few uniques
me8 
05.02.24 0%
sell
Coherus Bioscien.

Start price
Target price
Perf. (%)
€1.88
05.02.24
-
05.02.25
33.90%
17.02.24

Probably not worthwhile Investment
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
High valuation
kostojunior 
05.02.24 0%
sell
Fibrogen Inc.

Start price
Target price
Perf. (%)
€1.72
05.02.24
-
05.02.25
24.42%
17.02.24

Very low/no dividend yield expected
Risky Investment
EBIT decline/stagnation expected
High valuation
kostojunior 
05.02.24 0%
sell
Atara Biotherapeutics Inc.

Start price
Target price
Perf. (%)
€1.32
05.02.24
-
05.02.25
-43.81%
08.02.24

Good culture
Risky Investment
No uniques
me8 
05.02.24 0%
buy
Paypal Holdings Inc

Start price
Target price
Perf. (%)
€57.88
03.02.24
€59.00
03.02.25
6.63%
26.03.24

Top 10 in its market
Well known brand
Future proof or reliable business model
EBIT growth > 30% per year expected
Traumtanz 
03.02.24 50%
buy
Bristol-Myers Squibb

Start price
Target price
Perf. (%)
€40.84
02.02.24
-
-
03.02.24

Could be worthwhile Investment >10% per year
blaugold 
02.02.24 50%